Reply to: RAAS inhibitors in COVID-19: Not all are created equal! Jorge Gonçalves; Catarina D. Santos; Paula Fresco; Fernando Fernandez-Llimos;

Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity Jorge Gonçalves; Catarina D. Santos; Paula Fresco; Fernando Fernandez-Llimos;

RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one Rodolfo P. Rothlin; Facundo Pelorosso; Mariano Duarte; Liliana Nicolosi; Ignacio Fernandez Criado; María Victoria Salgado; Héctor Vetulli;